Treatment Registry
TR-1078 ActiveRecorded October 2026

Compounded semaglutide

Sold by Invyncible · Injection · device not recorded · every compounded semaglutide record

The program identifies an injection, but the delivery device has not been established.

Price

TermPublished rateCharged today
sema glycine — Program 1: 0.45mg weekly dose/2.5mg

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$149.00”

$149Published figureCharged todayNot verified
sema glycine — Program 2: .9mg weekly dose/5mg

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$250.00”

$250Published figureCharged todayNot verified
sema glycine — Program 3: 2mg weekly dose/10mg

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$325.00”

$325Published figureCharged todayNot verified
sema glycine — Starter Program: 0.45mg weekly dose/2.5mg

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$149.00”

$149Published figureCharged todayNot verified
sema glycine — Maintenance Program: .9mg weekly dose/10mg

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$325.00”

$325Published figureCharged todayNot verified
sema b12 — Program 1: 0.5mg weekly dose/2.5mg (5 Weeks)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$262.50”

$262.50Published figureCharged todayNot verified
sema b12 — Program 2: 1mg weekly dose/5mg (5 Weeks)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$318.75”

$318.75Published figureCharged todayNot verified
sema b12 — Program 3: 2mg weekly dose/10mg (5 Weeks)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$450.00”

$450Published figureCharged todayNot verified
sema b12 — Starter Program: 0.5mg weekly dose/2.5mg (5 Weeks)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$262.50”

$262.50Published figureCharged todayNot verified
sema b12 — Maintenance Program: 1mg weekly dose/10mg (10 Weeks)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$450.00”

$450Published figureCharged todayNot verified
Price sources
Visit Invyncible

We earn nothing from this link. It opens Invyncible's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationTerms reserve cancellation of an order by the platform and a credit if an already charged order is cancelled, and refer to a Return Policy without publishing a linked treatment-specific return rule in the reviewed legal page. The FAQ releases the pending authorization if a prescription is not approved; bank release timing varies. A patient cancellation cutoff, processed-prescription refund right and subscription renewal rule are not established. https://www.invyncible.com/legal https://www.invyncible.com/faq
MembershipNot disclosed
Consult feeNot disclosed

Recorded from invyncible.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Invyncible is a Nationwide Telemedicine, LLC brand. Independent Nationwide Telemedicine-affiliated medical practices supply medical services; Invyncible does not itself compound or dispense medication. A provider reviews intake before prescribing, with consultation requirements depending on the treatment and state rules. The general consent permits electronic, audio and video review; it does not fix one mandatory visit modality for every program. https://www.invyncible.com/legal https://www.invyncible.com/informed-consent https://www.invyncible.com/faq
  2. 2. October 2026 — The pharmacy network lists Empower, Strive, Center City, Partell, PerfectRx and MFV, and patients can request a different pharmacy or a prescription copy. A network listing does not assign every program to one pharmacy. Pharmacy choice can change price, availability and shipping. https://www.invyncible.com/compounding-pharmacies
  3. 3. October 2026 — The public pages do not itemize a separate ongoing membership or consultation fee. Terms say a purchased medical service is included in the collected total and an itemized invoice appears before purchase, without establishing the charge for a selected program in the reviewed public catalog. https://www.invyncible.com/legal
  4. 4. October 2026 — Published package prices and selected-option prices are retained as advertisements with an unverified payment and unstated billing interval. Approximate vial duration, financing installments, crossed-out prices and a two-month product title do not establish a calendar-month bill or renewal invoice. The final prescribed dose, fees and delivery charge require confirmation. https://www.invyncible.com/faq https://www.invyncible.com/shipping-information
  5. 5. October 2026 — The sema glycine page excludes Arkansas, California, Indiana, Minnesota, Oregon or South Carolina. This exclusion list is not an affirmative served-state roster; no complement is inferred. https://www.invyncible.com/invyncible-treatments/Semaglutide-B12-Glycine
  6. 6. October 2026 — The sema b12 page excludes California, Iowa, Oregon or Wisconsin. This exclusion list is not an affirmative served-state roster; no complement is inferred. https://www.invyncible.com/invyncible-treatments/semaglutide-b12-injections
  7. 7. October 2026 — Standard semaglutide explicitly uses vial sizes. Additive offers include semaglutide with B12 and with glycine/B12. The glycine/B12 page names Strive Pharmacy for that blend, with another pharmacy available by request; this is not an assignment for all semaglutide products. The B12 page explicitly permits synchronous or asynchronous consultation according to state requirements. https://www.invyncible.com/invyncible-treatments/Semaglutide-B12-Glycine https://www.invyncible.com/invyncible-treatments/semaglutide-b12-injections

11 further notes concern other Invyncible programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1078
Medication category
compounded semaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Invyncible — compounded semaglutide (TR-1078). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1078

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.